Healthcare
Live Price
Offline$2.43
+0.00% today
1Y Change
-33.61%
Window
Jun 30, 2025 → Jun 26, 2026
Coverage: 249 bars · Jun 30, 2025 → Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Organogenesis Holdings Inc. (ORGO) is a Healthcare stock with a market cap of $330.00M and listed on NASDAQ. The stock last traded around $2.43 and down 33.6% across the available one-year price window (Jun 30, 2025 → Jun 26, 2026). Baseline metrics include revenue growth of +17.0%, EPS growth of +2353.5%, a dividend yield of 0.0%. What stands out right now is revenue +17.0%, EPS +2353.5%, free cash flow -685.7% with operating margin 8.3% and ROIC 7.0%. Valuation is more restrained than many high-expectation growth names at P/E 8.8 and price/sales 0.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ORGO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
ORGO is 51.59 pts behind over the shared 1Y window.
ORGO had 56.62 pts deeper max drawdown than SPY.
ORGO beat SPY in 1 of 2 calendar years shown and trailed in 1.
ORGO
-33.61%
Normalized return
SPY
+17.99%
S&P 500
Excess Return
-51.59 pts
Relative to SPY
ORGO Max Drawdown
-65.75%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for ORGO and SPY.
| Year | ORGO | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -47.57% | +6.71% | -54.28 pts | SPY |
| 2025 | +41.53% | +11.19% | +30.34 pts | ORGO |
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.